Here's an idea for the fallen unicorn: Animal testing. A debate broke out on Twitter this weekend about whether the blood-testing startup could pivot in the wake of a criminal probe and a federal investigation.
Talking about Theranos with some E. Coast friends in health. Our prediction: A down round and then a pivot to animal testing.— Christina Farr (@chrissyfarr) May 7, 2016
And some mixed responses from the experts:
@chrissyfarr I've been pushing them that way!!! Huge market for rapid and easy testing in mice & huge need for small volumes— Ethan Weiss (@ethanjweiss) May 7, 2016
@chrissyfarr tiny market— Jonathan Hirsch (@JonathanHirsch) May 7, 2016